mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.02 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
0.02 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.02 |